- Kyoto Univ. research on COVID-19 treatment via iPS cell technology.
- Researchers aim to develop COVID-19 treatment by creating cytotoxic T cells in the bloodstream from iPS cells.
- Cytotoxic T cells play an important role in the immune response of cells.
- The Japan Agency for Medical Research and Development adopted the program in fiscal 2020.
Tags : JAPAN COVID-19, JAPAN CORONAVIRUS, KYOTO UNIVERSITY, iPS CELL TECHNOLOGY, CYTOTOXIC T CELLS, JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT,